PHARMACYTE BIOTECH INC's ticker is PMCB and the CUSIP is 71715X104. A total of 4 filers reported holding PHARMACYTE BIOTECH INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,000 | -28.6% | 635,257 | -11.2% | 0.00% | – |
| Q1 2019 | $35,000 | -18.6% | 715,257 | -39.0% | 0.00% | – |
| Q4 2018 | $43,000 | -10.4% | 1,172,654 | +38.6% | 0.00% | – |
| Q3 2018 | $48,000 | -36.0% | 845,890 | -23.1% | 0.00% | – |
| Q2 2018 | $75,000 | -11.8% | 1,099,692 | -31.3% | 0.00% | – |
| Q1 2018 | $85,000 | -4.5% | 1,601,220 | 0.0% | 0.00% | – |
| Q4 2017 | $89,000 | +67.9% | 1,601,220 | +73.0% | 0.00% | – |
| Q3 2017 | $53,000 | +71.0% | 925,763 | +63.3% | 0.00% | – |
| Q2 2017 | $31,000 | -43.6% | 567,015 | 0.0% | 0.00% | – |
| Q1 2017 | $55,000 | – | 567,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benedetti & Gucer, Inc. | 74,612 | $1,000 | 0.00% |
| Anchor Investment Management, LLC | 40,000 | $432 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| Fisher Asset Management, LLC | 401,610 | $4,000 | 0.00% |
| Main Street Research LLC | 35,000 | $0 | 0.00% |